Ovid Therapeutics (OVID) Tax Rate (2021 - 2022)
Ovid Therapeutics' (OVID) quarterly Tax Rate came in at 0.31% in Q1 2022, down 59.0% on a YoY basis from 0.76% in Q1 2021, and down 123.46% quarter-over-quarter from 1.33% in Q4 2021.
Powered by 
Analysis
Ovid Therapeutics (OVID) Tax Rate (2021 - 2022) Analysis & Trends
Ovid Therapeutics (OVID) has reported Tax Rate for 2 consecutive years, with 0.31% the latest figure, recorded in Q1 2022.
- For the quarter ending Q1 2022, Tax Rate fell 59.0% year-over-year to 0.31%; the trailing twelve-month figure through Dec 2022 stood at 0.09% (down 116.0% YoY), and the FY2021 full-year result was 1.07%, changed N/A from the prior year.
- Tax Rate retreated to 0.31% in Q1 2022 per OVID's latest filing, from 1.33% in the prior quarter.
- Across five years, Tax Rate topped out at 2.52% in Q3 2021 and bottomed at 10.29% in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 24.15% |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 22.08% |
| 10 | Ovid Therapeutics | 517.32 Mn | 400.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -0.31% |
| Dec 31, 2021 | 1.33% |
| Sep 30, 2021 | 2.52% |
| Jun 30, 2021 | -10.29% |
| Mar 31, 2021 | 0.28% |